Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics-Based Tailor-Made Strategy for Eradication of Helicobacter Pylori

NCT00149084 is registered in ClinicalTrials.gov with Hamamatsu University as lead sponsor.

NCT NCT00149084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00149084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics-Based Tailor-Made Strategy for Eradication of Helicobacter Pylori
Lead sponsor
Hamamatsu University
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2003
Completion date
Not reported
Enrollment
296
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

duodenal ulcer, gastric ulcer, gastritis, helicobacter infections